medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2018-2-150-154medsovet-2305Research ArticleГАСТРОЭНТЕРОЛОГИЯGASTROENTEROLOGYФункциональные нарушения органов пищеварения у младенцев: причины возникновения, критерии диагностики и возможности коррекции с помощью пробиотиковFUNCTIONAL GASTROINTESTINAL DISORDERS IN INFANTS: CAUSES OF OCCURRANCE, DIAGNOSTIC CRITERIA AND POSSIBILITIES OF CORRECTION WITH PROBIOTICSБогдановаН. М.BogdanovaN. M.

Кандидат медицинских наук.

PhD in medicine.

St. Petersburg

ЧерноваТ. М.ChernovaT. M.

Кандидат медицинских наук 

PhD in medicine

Северо-Западный федеральный медицинский исследовательский центр им. В.А. Алмазова Минздрава России; Институт перинатологии и педиатрииРоссияAlmazov North-Western Federal Medical Research University of the Ministry of Health of Russia. Institute of Perinatology and PaediatricsRussian FederationСанкт-Петербургский государственный педиатрический медицинский университет Минздрава РоссииРоссияSt. Petersburg State Paediatric Medical University of the Ministry of Health of RussiaRussian Federation20181402201802150154Copyright © Богданова Н.М., Чернова Т.М., 20182018Богданова Н.М., Чернова Т.М.Bogdanova N.M., Chernova T.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2305

В статье дано современное определение функциональных нарушений органов пищеварения, представлены критерии диагностики и возможный механизм их развития у новорожденных и младенцев в соответствии с Римскими критериями IV пересмотра (2016). Большая часть информации посвящена положительным эффектам использования пробиотического штамма Bifidobacterium animalis subsp. lactis (ВВ-12).

The article gives a modern definition of functional disorders of the digestive organs, presents diagnostic criteria and a possible mechanism for their development in newborns and infants in accordance with the Roman criteria for revision IV (2016). Much of the information is devoted to the positive effects of probiotic strain Bifidobacterium animalis subsp. lactis (ВВ-12).

функциональные нарушения органов пищеварениямладенецкишечная микробиотапробиотикииммунитетtoll-like рецепторы (TLRs)functional disorders of the digestive systeminfantintestinal microbiotaprobioticsimmunitytoll-like receptors (TLRs)ReferencesБельмер С.В., Хавкин А.И., Печкуров Д.В. Функциональные расстройства органов пищеварения у детей (в свете Римских критериев IV). Методическое пособие для врачей. Москва. 2016, с. 137.Бельмер С.В., Хавкин А.И., Печкуров Д.В. Функциональные расстройства органов пищеварения у детей (в свете Римских критериев IV). Методическое пособие для врачей. Москва. 2016, с. 137.Douglas A, Drossman DА (Editor). Rome III: The Functional Gastrointestinal Disorders. Degnon Associates, Inc., 3 edition. 2006, Р. 1048.Douglas A, Drossman DА (Editor). Rome III: The Functional Gastrointestinal Disorders. Degnon Associates, Inc., 3 edition. 2006, Р. 1048.Fagerberg UL, Lööf L, Merzoug RD, Hansson LO, Finkel Y. J Fecal calprotectin levels in healthy children studied with an improved assay. Pediatr Gastroenterol Nutr, 2003 Oct, 37(4): 468-72.Fagerberg UL, Lööf L, Merzoug RD, Hansson LO, Finkel Y. J Fecal calprotectin levels in healthy children studied with an improved assay. Pediatr Gastroenterol Nutr, 2003 Oct, 37(4): 468-72.Фролькис А.В. Функциональные заболевания желудочно-кишечного тракта. Л.: Медицина, 1991, 224 с.Фролькис А.В. Функциональные заболевания желудочно-кишечного тракта. Л.: Медицина, 1991, 224 с.Национальная программа оптимизации вскармливания детей первого года жизни в Российской Федерации. Союз педиатров России. М., 2010: 39-42.Национальная программа оптимизации вскармливания детей первого года жизни в Российской Федерации. Союз педиатров России. М., 2010: 39-42.Захарова И.Н. Срыгивание и рвота у детей: что делать? Consilium Medicum. Педиатрия, 2009, 3: 16-20.Захарова И.Н. Срыгивание и рвота у детей: что делать? Consilium Medicum. Педиатрия, 2009, 3: 16-20.Gold BD. Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications? Am J Gastroenterol, 2006 Mar, 101(3): 641-4.Gold BD. Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications? Am J Gastroenterol, 2006 Mar, 101(3): 641-4.Orenstein SR, Shalaby TM, Kelsey SF, Frankel E. Natural history of infant reflux esophagitis: symptoms and morphometric histology during one year without pharmacotherapy. Am J Gastroenterol, 2006, 101(3): 628-40.Orenstein SR, Shalaby TM, Kelsey SF, Frankel E. Natural history of infant reflux esophagitis: symptoms and morphometric histology during one year without pharmacotherapy. Am J Gastroenterol, 2006, 101(3): 628-40.Romanello S, Spiri D, Marcuzzi E, Zanin A, Boizeau P, et al Association between childhood migraine and history of infantile colic. JAMA, 2013 Apr 17, 309(15): 1607-12.Romanello S, Spiri D, Marcuzzi E, Zanin A, Boizeau P, et al Association between childhood migraine and history of infantile colic. JAMA, 2013 Apr 17, 309(15): 1607-12.Gelfand AA, Goadsby PJ, Allen IE. The relationship between migraine and infant colic: a systematic review and meta-analysis. Cephalalgia, 2015 Jan, 35(1): 63-72.Gelfand AA, Goadsby PJ, Allen IE. The relationship between migraine and infant colic: a systematic review and meta-analysis. Cephalalgia, 2015 Jan, 35(1): 63-72.Drossman ro A, Hasler W L. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology, 2016, 150(6): 1257-61.Drossman ro A, Hasler W L. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology, 2016, 150(6): 1257-61.Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology, 2009, 136: 2003–2014.Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology, 2009, 136: 2003–2014.Rhee SH, Potoulakis C, Maye EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol, 2009, 6: 309–314.Rhee SH, Potoulakis C, Maye EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol, 2009, 6: 309–314.Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol, 2010, 7: 163-73.Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol, 2010, 7: 163-73.Самсонов А. А., Андреев Д. Н., Дичева Д. Т. Синдром раздраженного кишечника с позиций современной гастроэнтерологии. Фарматека, 2014, 18: 7-13.Самсонов А. А., Андреев Д. Н., Дичева Д. Т. Синдром раздраженного кишечника с позиций современной гастроэнтерологии. Фарматека, 2014, 18: 7-13.Berrington JE, Stewart CJ, Cummings SP, Embleton ND. The neonatal bowel microbiome in health and infection. Curr Opin Infect Dis, 2014, 27: 236–43.Berrington JE, Stewart CJ, Cummings SP, Embleton ND. The neonatal bowel microbiome in health and infection. Curr Opin Infect Dis, 2014, 27: 236–43.Groer MW, Luciano AA, Dishaw LJ, Ashmeade TL, Miller E, Gilbert JA. Development of the preterm infant gut microbiome: a research priority. Microbiome, 2014, 2: 38.Groer MW, Luciano AA, Dishaw LJ, Ashmeade TL, Miller E, Gilbert JA. Development of the preterm infant gut microbiome: a research priority. Microbiome, 2014, 2: 38.Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, Immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol, 2010, 7: 163–173.Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, Immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol, 2010, 7: 163–173.Gisbert JP, McNicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis, 2009, 41(1): 56-66.Gisbert JP, McNicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis, 2009, 41(1): 56-66.Корниенко Е.А., Вагеманс Н.В., Нетребенко О.К. Младенческие кишечные колики: современные представления о механизмах развития и новые возможности терапии. Вопросы современной педиатрии, 2010, 5(33): 176–183.Корниенко Е.А., Вагеманс Н.В., Нетребенко О.К. Младенческие кишечные колики: современные представления о механизмах развития и новые возможности терапии. Вопросы современной педиатрии, 2010, 5(33): 176–183.Benninga S, Nurko MA, Faure C, Hyman PE, Roberts I, Schechter NL. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterology, 2016, 150(6): 1443–1455.Benninga S, Nurko MA, Faure C, Hyman PE, Roberts I, Schechter NL. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterology, 2016, 150(6): 1443–1455.Бельмер С.В., Хавкин А.И., Печкуров Д.В. Запоры функционального происхождения у детей (взгляд через призму Римского консенсуса IV). Лечащий врач, 2017, 2.Бельмер С.В., Хавкин А.И., Печкуров Д.В. Запоры функционального происхождения у детей (взгляд через призму Римского консенсуса IV). Лечащий врач, 2017, 2.FAO/WHO. Working group on drafting guidelines for the evaluation of probiotics in food. Guidelines for the evaluation of probiotics in food. 2002.FAO/WHO. Working group on drafting guidelines for the evaluation of probiotics in food. Guidelines for the evaluation of probiotics in food. 2002.Reid G. Regulatory and clinical aspects of dairy probiotics. FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina, 2001, 1–34. Available from: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.Reid G. Regulatory and clinical aspects of dairy probiotics. FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina, 2001, 1–34. Available from: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.Agostoni C, Axelsson I, Braegger C, Goulet O, Koletzko B, Michaelsen KF, Rigo J, Shamir R, Szajewska H, Turck D, Weaver LT, ESPGHAN Committee on Nutrition Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr, 2004 Apr, 38(4): 365-74.Agostoni C, Axelsson I, Braegger C, Goulet O, Koletzko B, Michaelsen KF, Rigo J, Shamir R, Szajewska H, Turck D, Weaver LT, ESPGHAN Committee on Nutrition Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr, 2004 Apr, 38(4): 365-74.Cruchet S, Furnes R, Maruy A, Hebel E, Palacios J, Medina F, Ramirez N, Orsi M, Rondon L, Sdepanian V, Xóchihua L, Ybarra M, Zablah RA. The Use of Probiotics in Pediatric Gastroenterology: A Review of the Literature and Recommendations by Latin-American Experts. Pediatric Drugs, 2015 June, 17(Issue 3): 199-216.Cruchet S, Furnes R, Maruy A, Hebel E, Palacios J, Medina F, Ramirez N, Orsi M, Rondon L, Sdepanian V, Xóchihua L, Ybarra M, Zablah RA. The Use of Probiotics in Pediatric Gastroenterology: A Review of the Literature and Recommendations by Latin-American Experts. Pediatric Drugs, 2015 June, 17(Issue 3): 199-216.Floch MH. Recommendations for probiotic use in humans-a 2014 update. Pharmaceuticals (Basel), 2014 Oct 10, 7(10): 999-1007.Floch MH. Recommendations for probiotic use in humans-a 2014 update. Pharmaceuticals (Basel), 2014 Oct 10, 7(10): 999-1007.Indrio F. Study concludes L. reuteri not effective for infant colic, but findings may be limited by participants’ heterogeneity. Evid Based Med, 2014 Dec, 19(6): 215.Indrio F. Study concludes L. reuteri not effective for infant colic, but findings may be limited by participants’ heterogeneity. Evid Based Med, 2014 Dec, 19(6): 215.Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M8, Brazzoduro E, Del Vecchio A, Tafuri S, Francavilla R. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr, 2014 Mar, 168(3): 228-33.Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M8, Brazzoduro E, Del Vecchio A, Tafuri S, Francavilla R. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr, 2014 Mar, 168(3): 228-33.Penna FJ, Péret LA, Vieira LQ, Nicoli JR. Probiotics and mucosal barrier in children. Curr Opin Clin Nutr Metab Care, 2008 Sep, 11(5): 640-4.Penna FJ, Péret LA, Vieira LQ, Nicoli JR. Probiotics and mucosal barrier in children. Curr Opin Clin Nutr Metab Care, 2008 Sep, 11(5): 640-4.Grześkowiak Ł, Grönlund MM, Beckmann C, Salminen S, von Berg A, Isolauri E. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe, 2012 Feb, 18(1): 7-13.Grześkowiak Ł, Grönlund MM, Beckmann C, Salminen S, von Berg A, Isolauri E. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe, 2012 Feb, 18(1): 7-13.Savino F, Cordisco L, Tarasco V, Locatelli E, Di Gioia D, Oggero R, Matteuzzi D. Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiol, 2011 Jun 30, 11: 157.Savino F, Cordisco L, Tarasco V, Locatelli E, Di Gioia D, Oggero R, Matteuzzi D. Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiol, 2011 Jun 30, 11: 157.Jungersen M, Wind A. et al. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®). Microorg, 2014, 2: 92-110.Jungersen M, Wind A. et al. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®). Microorg, 2014, 2: 92-110.Laparra JM, Sanz Y. Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium. Lett Appl Microbiol, 2009 Dec, 49(6): 695-701.Laparra JM, Sanz Y. Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium. Lett Appl Microbiol, 2009 Dec, 49(6): 695-701.Matsumoto M, Ohishi H, Benno Y. H+-ATPase activity in Bifidobacterium with special reference to acid tolerance. Int J Food Microbiol, 2004 May 15, 93(1): 109-13.Matsumoto M, Ohishi H, Benno Y. H+-ATPase activity in Bifidobacterium with special reference to acid tolerance. Int J Food Microbiol, 2004 May 15, 93(1): 109-13.Martins FS, Silva AA, Vieira AT, Barbosa FH, Arantes RM, Teixeira MM, Nicoli JR. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol, 2009 Aug, 191(8): 623-30.Martins FS, Silva AA, Vieira AT, Barbosa FH, Arantes RM, Teixeira MM, Nicoli JR. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol, 2009 Aug, 191(8): 623-30.Amund OD, Ouoba LI, Sutherland JP, Ghoddusi HB. Assessing the effects of exposure to environmental stress on some functional properties of Bifidobacterium animalis ssp. lactis. Benef Microbes, 2014 Dec, 5(4): 461-9.Amund OD, Ouoba LI, Sutherland JP, Ghoddusi HB. Assessing the effects of exposure to environmental stress on some functional properties of Bifidobacterium animalis ssp. lactis. Benef Microbes, 2014 Dec, 5(4): 461-9.Хавкин А.И., Комарова О.Н. Нарушение микробиоценоза кишечника у детей (пособие для врачей). Москва, 2016, 48 с.Хавкин А.И., Комарова О.Н. Нарушение микробиоценоза кишечника у детей (пособие для врачей). Москва, 2016, 48 с.Szajewska H, Guandalini S, Morelli L, Van Goudoever JB, Walker A. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J Pediatr Gastroenterol Nutr, 2010, 51(2): 203–9. doi: 10.1097/MPG.0b013e3181dc0d93.Szajewska H, Guandalini S, Morelli L, Van Goudoever JB, Walker A. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J Pediatr Gastroenterol Nutr, 2010, 51(2): 203–9. doi: 10.1097/MPG.0b013e3181dc0d93.Taipale T, Pienihäkkinen K, Isolauri E, Larsen C, Brockmann E, Alanen P, Jokela J, Söderling E. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr, 2011, 105(3): 409-16.Taipale T, Pienihäkkinen K, Isolauri E, Larsen C, Brockmann E, Alanen P, Jokela J, Söderling E. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr, 2011, 105(3): 409-16.

The authors declare that there are no conflicts of interest present.